美邦股份:2026年第一次临时股东会决议公告

Core Viewpoint - The company, Meibang Co., announced the approval of several key proposals during its first extraordinary shareholders' meeting of 2026, including the conclusion of fundraising projects and the allocation of surplus funds to enhance liquidity [2]. Group 1 - The company approved the proposal to conclude fundraising projects and permanently allocate surplus funds to enhance liquidity [2]. - The company also approved a proposal to apply for a credit limit from banks [2]. - Additionally, the company approved a proposal to provide guarantees for its subsidiaries [2].

Shaanxi Meibang Pharmaceutical -美邦股份:2026年第一次临时股东会决议公告 - Reportify